Ramses Sadek, PhD

Professor & Director of Cancer Center Biostatistics Core
PhD (Statistics & Educational Psychology), University of Georgia (Athens, Georgia), 1992


(706) 721-6930
room number CN-4123
Ramses Sadek, PhD


Extensive research experience in the areas of Oncology, diagnostics devices, HIV, vaccine, generic bioequivalence, and sickle cell disease with over 200 protocols. Well-established records and accomplishments in observational studies, notational datasets analysis, and clinical trials design, analysis, and submission with FDA interaction. Experience in academia, industry, government, non-for-profit organization with multidisciplinary sittings and staff and project management.  Dr. Sadek has an extensive experience as individual contributor in design and analysis of several areas of, clinical trials, SAS programming, patient reported outcomes, health economics, quality of life assessment, public health and Epidemiology with co-authorships in leading professional journals. Professional activities include adjunct faculty positions, data safety monitoring committees, professional journal editorials, and member of several scientific organizations and invited speaker in several meetings.

In recent years, Dr. Sadek has focused his attention on a few specific areas of research including, health disparity, multiplicity, incomplete data, clinical trial design, and data mining methods. At the present, his current methodological research interests can be categorized into two broad areas: a) health disparity and b) clinical trials design with emphasis on new development in Oncology.




  • Nagy Youssef, Dheeraj Ravilla , Cherishma Patel , Mark Yassa , Ramses Sadek , Li Fang Zhang, Laryssa McCloud, William V. McCall and Peter B. Rosenquist (2019).Magnitude of Reduction and Speed of Remission of Suicidality for Low Amplitude Seizure Therapy (LAP-ST) Compared to Standard Right Unilateral Electroconvulsive Therapy: A Pilot Double-Blinded Randomized Clinical Trial. Brain Sci. (2019) 9(5), 99. https://www.mdpi.com/2076-3425/9/5/99/pdf
  • Chung JM, Simmerman EL, Sadek RF, Wojtowicz S, Dillard TA, Albo D, Thomson NB, Schroeder C (2019) Financial Analysis of Free Lung Cancer Screening Program Shows Profitability Using Broader NCCN Guidelines. Ann Thorac Surg. 2019 Mar;107(3):885-890.
  • Anh Thu Nguyen, Ashwin, Ajith, Vera Dobos, Daniel Horuzsko, Ali Arbab, Ramses Sadek, Anatolij Horuzsko. The Innate immune receptor TREM-1 promotes liver injury and fibrosis. Submitted to the Journal of clinical investigation (2018).
  • Schroeder C, Chung JM, Simmerman E, Sadek R, Wojtowicz S, Dillard T, Albo D, Thomson. Financial analysis of a free lung cancer screening program shows profitability despite applying broader National Comprehensive Cancer Network Guidelines” and submitted to the Annals of Thoracic Surgery. 2018.
  • El Osta B, Hu F, Sadek R, Chintalapally R and Tang S (2017): Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials. Critical Reviews in Oncology / Hematology 119: 1–12.
  • Nayak-Kapoor A, Hao Z, Sadek R, Dobbins R, Marshall L, Vahanian  N, Ramsey W, Kennedy E, Mautino M, Link C, Lin R, Royer-Joo S, Liang X, Morrissey K, Mahrus S, McCall B, Pirzkall A, Munn D, Janik J, Khleif SPhase Ia Study of the Indoleamine 2,3-dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) in Patients with Recurrent Advanced Solid Tumors. Submitted to AACR journal.
  • Simmerman E, Thomson N, Dillard T, Hao Z, Sadek R, Khleif S, Schroedr C (2017). Free lung cancer screening trends towards a twofold increase in lung cancer prevalence in the underserved Southeastern United States. Southern Medical Journal Vol 110, Number 3, 188-194 
  • Zhao J, Xia Y, Kaminski J, Hao Z, Mott F, Campbell J, Sadek R, Kong FM (2016). Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.. PLoS One. 11(6):e0157455. doi: 0.1371/ journal.pone.0157455. eCollection 2016. PMID:27300551
  • Jin JY, Wang W, Ten Haken RK, Chen J, Bi N, Sadek R, Zhang H, Lawrence TS, Kong FM (2015). Use a survival model to correlate single-nucleotide polymorphisms of DNA repair genes with radiation dose-response in patients with non-small cell lung cancer. Radiother Oncol. 117(1):77-82. doi: 10.1016/j.radonc.2015.07.024. Epub 2015 Aug 4.PMID:6253951
  • Campbell J, Zhao J, Zaenger D, Colton L, Madi R, Dasher B, Ferguson C, Lewis R, Smith A, Sadek R, Terris M, Kong F (2015). No Significant Difference in Overall Survival between Caucasian and African Americans Patient with Prostate Cancer: An Analysis of 1338 Patients from a Single Institution. International journal of radiation oncology, biology, physics 93(3):E244